Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity-Reference-Cited by-同舟云学术

Disarmed anthrax toxin delivers antisense oligonucleotides and siRNA with high efficiency and low toxicity

Published:2015-12 Issue: Volume:220 Page:316-328
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Dyer Paul D.R.,Shepherd Thomas R.,Gollings Alexander S.,Shorter Susan A.,Gorringe-Pattrick Monique A.M.,Tang Chun-Kit,Cattoz Beatrice N.,Baillie Les,Griffiths Peter C.,Richardson Simon C.W.

Funder

Science and Technology Funding Council

The University of Greenwich

GUEL

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Non-viral vectors for gene based therapy;Yin;Nat. Rev. Genet.,2014

2. Quo vadis polyplex?;Merkel;J. Control. Release,2014

3. Fomivirsen: clinical pharmacology and potential drug interactions;Geary;Clin. Pharmacokinet.,2002

4. Antisense approach to inflammatory bowel disease: prospects and challenges;Marafini;Drugs,2015

5. Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia;Rader;Circulation,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Proteins for Cell Entry;Molecular Pharmaceutics;2023-09-14

2. Endosomal escape for cell-targeted proteins. Going out after going in;Biotechnology Advances;2023-03

3. Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context;BioDrugs;2023-02-02

4. Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms;Cell Reports;2022-03

5. Novel Aspects of the SubA Subunit of the Subtilase Cytotoxin;Toxins;2022-02-21